Search: onr:"swepub:oai:research.chalmers.se:8c72d91c-d4b4-47f2-b0a6-b99883ae115f" >
Two statins and cro...
-
Blomgren, FredrikChalmers tekniska högskola,Chalmers University of Technology
(author)
Two statins and cromolyn as possible drugs against the cytotoxicity of A beta(31-35) and A beta(25-35) peptides: a comparative study by advanced computer simulation methods
- Article/chapterEnglish2022
Publisher, publication year, extent ...
-
2022
-
Royal Society of Chemistry (RSC),2022
-
electronicrdacarrier
Numbers
-
LIBRIS-ID:oai:research.chalmers.se:8c72d91c-d4b4-47f2-b0a6-b99883ae115f
-
https://research.chalmers.se/publication/530425URI
-
https://doi.org/10.1039/d2ra01963aDOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:art swepub-publicationtype
-
Subject category:ref swepub-contenttype
Notes
-
In this work, possible effective mechanisms of cromolyn, atorvastatin and lovastatin on the cytotoxicity of A beta(31-35) and A beta(25-35) peptides were investigated by classical molecular dynamics and well-tempered metadynamics simulations. The results demonstrate that all the drugs affect the behavior of the peptides, such as their ability to aggregate, and alter their secondary structures and their affinity to a particular drug. Our findings from the computed properties suggest that the best drug candidate is lovastatin. This medicine inhibits peptide aggregation, adsorbs the peptides on the surface of the drug clusters, changes the secondary structure and binds to MET35, which has been seen as the reason for the toxicity of the studied peptide sequences. Moreover, lovastatin is the drug which previously has demonstrated the strongest ability to penetrate the blood-brain barrier and makes lovastatin the most promising medicine among the three investigated drugs. Atorvastatin is also seen as a potential candidate if its penetration through the blood-brain barrier could be improved. Otherwise, its properties are even better than the ones demonstrated by lovastatin. Cromolyn appears to be less interesting as an anti-aggregant from the computational data, in comparison to the two statins.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Rodin, AlexanderChalmers tekniska högskola,Chalmers University of Technology
(author)
-
Chrobak, WojciechChalmers tekniska högskola,Chalmers University of Technology
(author)
-
Pacut, Dawid WojciechChalmers tekniska högskola,Chalmers University of Technology
(author)
-
Swenson, Jan,1966Chalmers tekniska högskola,Chalmers University of Technology(Swepub:cth)f5xjs
(author)
-
Ermilova, Inna,1983Chalmers tekniska högskola,Chalmers University of Technology(Swepub:cth)ermilova
(author)
-
Chalmers tekniska högskola
(creator_code:org_t)
Related titles
-
In:RSC Advances: Royal Society of Chemistry (RSC)12:21, s. 13352-133662046-2069
Internet link
Find in a library
To the university's database